Merck KGaA (OTCMKTS:MKGAF) Shares Up 0.8% – Time to Buy?

Shares of Merck KGaA (OTCMKTS:MKGAF) rose 0.8% during trading on Thursday . The stock traded as high as $151.95 and last traded at $150.50. Approximately 171 shares changed hands during trading, a decline of 67% from the average daily volume of 522 shares. The stock had previously closed at $149.25.

Analyst Ratings Changes

Separately, The Goldman Sachs Group upgraded shares of Merck KGaA to a “strong-buy” rating in a research report on Thursday, September 19th.

Merck KGaA Stock Performance

The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The stock’s 50-day moving average price is $158.98 and its 200-day moving average price is $172.07. The company has a market cap of $19.43 billion, a P/E ratio of 22.08 and a beta of 0.96.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.